Phenindione: Difference between revisions
m (Protected "Phenindione": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
No edit summary |
||
| Line 24: | Line 24: | ||
| routes_of_administration = Oral | | routes_of_administration = Oral | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
'''Phenindione''' is an [[anticoagulant]] which functions as a [[Vitamin K]] antagonist. | |||
[[Hypersensitivity]] has been observed.<ref name="pmid15743920">{{cite journal |title=Characterization of the T-cell response in a patient with phenindione hypersensitivity |journal=J. Pharmacol. Exp. Ther. |volume=313 |issue=3 |pages=1058–65 |date=June 2005 |pmid=15743920 |doi=10.1124/jpet.105.083758 |url=http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=15743920 |display-authors=3 |author1=Naisbitt DJ |author2=Farrell J |author3=Chamberlain PJ |author-separator=, |last4=Hopkins |first4=JE |last5=Berry |first5=NG |last6=Pirmohamed |first6=M |last7=Park |first7=BK}}</ref> | |||
==External | ==External Links== | ||
* {{DiseasesDB|30536}} | * {{DiseasesDB|30536}} | ||
==References== | |||
{{reflist|2}} | |||
{{Antithrombotics}} | {{Antithrombotics}} | ||
[[Category:Drug]] | |||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Anticoagulants]] | [[Category:Anticoagulants]] | ||
Latest revision as of 00:32, 26 July 2014
 | |
| Clinical data | |
|---|---|
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code | |
| Pharmacokinetic data | |
| Protein binding | 88% |
| Elimination half-life | 5 to 10 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C15H10O2 |
| Molar mass | 222.239 g/mol |
|
WikiDoc Resources for Phenindione |
|
Articles |
|---|
|
Most recent articles on Phenindione Most cited articles on Phenindione |
|
Media |
|
Powerpoint slides on Phenindione |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Phenindione at Clinical Trials.gov Clinical Trials on Phenindione at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Phenindione
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Phenindione Discussion groups on Phenindione Patient Handouts on Phenindione Directions to Hospitals Treating Phenindione Risk calculators and risk factors for Phenindione
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Phenindione |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Phenindione is an anticoagulant which functions as a Vitamin K antagonist.
Hypersensitivity has been observed.[1]
External Links
References
- ↑ Naisbitt DJ; Farrell J; Chamberlain PJ; et al. (June 2005). "Characterization of the T-cell response in a patient with phenindione hypersensitivity". J. Pharmacol. Exp. Ther. 313 (3): 1058–65. doi:10.1124/jpet.105.083758. PMID 15743920. Unknown parameter
|author-separator=ignored (help)
- Pages with script errors
- Pages with citations using unsupported parameters
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Cardiovascular Drugs
- Anticoagulants